z-logo
open-access-imgOpen Access
P917: HOW COMORBID ARE OUR MYELOMA PATIENTS AND HOW MANY MAKE IT TO THE SECOND‐LINE TREATMENT: REAL‐WORLD DATA OF 251 MYELOMA PATIENTS TREATED IN THE HEMATOLOGICAL NETWORK OF THE OEGK
Author(s) -
Keil F.,
Attalla P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846536.28395.e7
Subject(s) - medicine , comorbidity , multiple myeloma , kidney disease , concomitant , diabetes mellitus , hematology , dialysis , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here